A man walking past an AstraZeneca sign in Macclesfield, England. Phil Noble/Reuters The UK pharmaceutical company AstraZeneca is likely to run a second global trial to assess its COVID-19 vaccine's efficacy, its CEO told Bloomberg News on Thursday. AstraZeneca and the University of Oxford announced Monday that preliminary results indicated their two-dose vaccine could be up to 90% effective at preventing COVID-19. But the team later said an error in the trial left some participants with half-doses instead of full doses. Experts said that error cast doubt on the validity of the efficacy rate and warranted further study. Visit Business Insider's homepage for more stories. Experts' trust in the validity of AstraZeneca's reported COVID-19 vaccine data has quickly eroded.AstraZeneca and the University of Oxford said on Monday that their coronavirus vaccine was found to be up to 90% effective based on preliminary results from studies of 23,000 volunteers in Brazil and the UK.But reports of an error during its initial trial prompted a barrage of questions.On Thursday, the pharmaceutical company's CEO, Pascal Soriot, acknowledged the concerns and said it would likely conduct a second trial of the two-dose vaccine, Bloomberg News first reported Thursday."Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Soriot told Bloomberg News.The error meant about 2,700 participants got 1 1/2 vaccine doses instead of the intended two.

BING NEWS:
  • UPDATE 2-AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition
    CEO Soriot eligible to earn as much as $23.7 million this year (Adds details on votes and background throughout) April 11 (Reuters) - AstraZeneca shareholders on Thursday approved a 2024 pay ...
    04/10/2024 - 1:00 pm | View Link
  • AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition
    (Reuters) -AstraZeneca shareholders on Thursday approved a 2024 pay policy which will boost CEO Pascal Soriot's remuneration to as much as 18.9 million pounds ($23.7 million) this year, but over a ...
    04/10/2024 - 1:00 pm | View Link
  • AstraZeneca vaccine
    Getty Images A patient attends the Penrith Auction Mart Vaccination Centre to receive the AstraZeneca Covid-19 vaccine There was talk of a tie-up between Oxford University and US pharmaceutical ...
    12/18/2023 - 11:07 pm | View Link
  • Covid-19: Malaysia donates over 800,000 AstraZeneca vaccine doses to Bangladesh, Laos
    KUALA LUMPUR: The government has decided to donate 559,200 AstraZeneca vaccine doses to Bangladesh and 283,400 doses to Laos to ensure the countries in need have equal access to Covid-19 vaccines.
    12/6/2021 - 8:38 am | View Link
  • AstraZeneca Covid-19 Coronavirus Vaccine Begins Phase 3 Trial In U.S.
    Nevertheless, the Phase 3 clinical trial in the U.S. for AstraZeneca’s Covid-19 coronavirus vaccine candidate is now officially runnin' runnin. About a quarter of the 80 total clinical sites ...
    08/31/2020 - 6:14 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News